发明名称 |
Use of functionalized magnetic nanoparticles in cancer detection and treatment |
摘要 |
The present invention provides methods of detecting a cancer cell in an individual, methods of grading a cancer, and methods of treating a cancer. The methods involve use of functionalized magnetic nanoparticles that comprise a moiety that provides for selective association with, and/or metabolic uptake into, a cancer cell. |
申请公布号 |
US9011913(B2) |
申请公布日期 |
2015.04.21 |
申请号 |
US200912934048 |
申请日期 |
2009.04.01 |
申请人 |
The Regents of the University of California |
发明人 |
Akhtari Massoud;Engel Jerome |
分类号 |
A61K9/14;A61K49/18;A61K41/00;A61K47/48;B82Y5/00 |
主分类号 |
A61K9/14 |
代理机构 |
Bozicevic, Field & Francis, LLP |
代理人 |
Bozicevic, Field & Francis, LLP ;Borden Paula A. |
主权项 |
1. A method of detecting a cancer cell in an individual, the method comprising
a) administering to the individual a pharmaceutical composition comprising:
i) a functionalized magnetic nanoparticle (MNP) of the formula M-S-(L)-Z, wherein M is a magnetic core, S is a polymer, L is an optional linker, and Z is a functional moiety that has differential affinity for and/or metabolic uptake into a cancer cell,wherein the functional moiety is corticotropin releasing hormone, and wherein the cancer cell is a pituitary tumor cell;wherein the functional moiety is adrenocorticotropin hormone, and wherein the cancer cell is an adrenal dysplasia or tumor; orwherein the functional moiety is 2-deoxyglucose (2DG) and wherein the 2DG is linked via the 6-OH group of the 2DG; andii) a pharmaceutically acceptable carrier; and b) detecting the functionalized MNP in association with the cancer cell. |
地址 |
Oakland CA US |